FDA Recalls Over 140,000 Bottles of Cholesterol Medication After ‘Failed Dissolution Specifications

Federal health officials have announced a large-scale recall of more than 140,000 bottles of a widely used cholesterol medication after the drug failed to meet quality standards during testing. According to the U.S. Food and Drug Administration (FDA), several bottle sizes of Atorvastatin Calcium Tablets (10 mg), the generic form...

The post FDA Recalls Over 140,000 Bottles of Cholesterol Medication After ‘Failed Dissolution Specifications appeared first on Menz Mag.